SUMMARY
INTRODUCTION
In women, ovarian cancer is the fifth most common cancer, it is the second most common one among the gynecologic cancers, and the most common cause of gynecologic cancer deaths (1, 2) . The incidence of ovarian cancer increases with age, and the average age at diagnosis is 63. The highest incidence is in the age group of 75-79 (2) . ovarian cancer symptoms might not be seen for a long time in the vast majority of women.
Most of the time developing symptoms are not specific.
For this reason, they are often at an advanced stage when they are diagnosed (3) . surgical staging is being performed in ovarian cancer, and since the stage has a great effect on the prognosis staging laparotomy is of great importance (4) . Treatment depends on the stage of the patient following primary surgery. The main purpose is surgically removing the maximum amount of tumor and leaving no tumor behind, because there is a significant relationship between the residual tumor volume and survival (5) .
The purpose of this study is to review the cases of epithelial ovarian cancer retrospectively and to investigate the epidemiological and prognostic factors, to examine the parameters influencing the survival. test was used for the analysis of survival, log rank test was used for the comparison of these curves. Data were given as arithmetic mean ± standard deviation and p values of <0.05 was considered as statistically significant.
MATERIALS AND METHODS

In
RESULTS
The age of the patients at diagnosis were between 19-80, and the average age was found as 52.8 ± 13. The most common application was in the age group of 51-60 with 52 patients (34.9%), and this was followed by 38 (25.5%) and 26 (17.4%) patients in the age groups of 61-70 and 41-50, respectively (Table I) . When the patients were classified as older or younger than 65 years-old and the effect of age on survival was investigated there was no significant difference between the two groups (p> 0.05) (Table II, Figure 1 
DISCUSSION
Epithelial ovarian cancer is commonly seen in perimenopausal and postmenopausal women, while the incidence of peak period is emphasized as the 60 years of age (6) . The mean age in our patients was 52 ± 13 years and in the vast majority of cases the ages were between 51-70 with a rate of 60.4%. Scholz et al (7) retrospectively evaluated Stage IV ovarian cancer cases and found the average age as 59.9 (37-76) (7) . In another study, it was emphasized that approximately 85% of patients with ovarian cancer are over 50 yearsold (8) . Ovarian cancer appears to be particularly a disease of an advanced age, and it is almost hiding behind the curtain of a fog because of other diseases accompanying at this age and complaints depend on them. In our study abdominal distension was seen in 59.1% of patients and was the most common complaint which was followed by abdominal pain with a rate of 20.8%. vaginal bleeding was found in 8.7%, and pelvic pain was found in 8.7%. In accordance with our study
Olson SH et al. (9) also reported abdominal fullness, swelling and pressure sensation as the most commmon complaint (71%), and the second most frequent complaint was reported as abdominal pain (52%).
These non-specific symptoms cause delays in diagnosis, thus patients are often diagnosed at an advanced stage. operations were evaluated cases with a tumor diameter below 1 cm ranges from 33% to 67% (12, 13) . The cases of our clinic are consistent with the literature. In addition the need for experienced surgeons in this subject for optimal cytoreduction is emphasized and in the literature the differences in the distribution of patients were explained in this way (14) .
In our study, there was no significant effect of age on survival. Similarly, studies in the literature investigating the prognostic significance of age studied the survival time of patients as well, and emphasized that young age is an independent prognostic factor (15, 16) . Another study in which only the reproductive period was evaluated revealed that age does not have a prognostic effect on survival (17) . However, the duration of survival in the geriatric group was significantly less than the group of non-elderly, and there are studies showing that even if adjusting for stage and residual disease is performed older groups have lower survival rate (18, 19) .
The majority of studies show that there is a larger tumor left post-operatively in older patients and that the patients have a shorter survival time. In these studies, it has been emphasized that aggressive surgery cannot be performed in the geriatric group, that is why the residual tumor diameter might be larger in size (18) (19) (20) (21) . In our study, while we had 125 cases under 65
years-old, we had 24 cases over 65 years-old and due to this small number of geriatric patients a meaningful conclusion could not be reached.
The studies emphasized that maximum diameter of residual tumor remaining after the operation has a prognostic value (22, 23) . In our patients the mean survival time of patients with no residual tumor or residual tumor <1 cm were similar, while the decrease in mean survival time of patients with residual tumor 1 cm or more was statistically significant (Figure 4.3) . In the literature the definition of optimal surgery according to remaining residual tumor diameter has changed in the recent years. In 1970s ≤ 2 cm was sufficient for optimal surgery (24, 25) . Afterwards, in the early 1980s
optimal surgery was defined as ≤ 3 cm, and in the late 1980s it has been revised as ≤ 1 cm (26, 27) . In accordance with our study, publications in the literature also indicate the maximum residual tumor diameter as a prognostic factor and observed that survival increases as the residual tumor size decreases (12, 13, 22, 23) . In our study, although the survival time in the group with a residual tumor diameter <1 cm was not statistically different, the fact that it is 11.3 months better than the group with no residual tumor could be explained by the small number of cases or with the discussion that cases with a residual tumor <1 cm could be considered as optimal as well. and 27% in patients with advanced stages of disease (28) . In another 5-year survival rates of stage I, II, III and IV were reported as 72% and 42%, 21% and 6%, respectively, and stage was emphasized as the prognostic factor concerning the survival (10) . In the literature, even though there is a consensus on decreased survival by the advanced stage, the survival times vary.
In a study remarking on this variety, the mean time in the advanced cases were emphasized as 12-21 months and it was stated that ovarian cancer surgery should be performed by the gynecologic oncologists (29) .
In conclusion, stage and residual tumor size after surgery was found as the prognostic factors that influence the survival. For a better prognosis of patients, early diagnosis of ovarian cancer and in the cases operated maximum reduction in the residual tumor size should be targeted.
